MODULATORS OF CRTH2 REZEPTOR ACTIVITY FOR THE TREATMENT OF PROSTAGLANDIN D2 MEDIATED DISEASES
申请人:AstraZeneca AB
公开号:EP1799658A2
公开(公告)日:2007-06-27
[EN] NOVEL COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES
申请人:ASTRAZENECA AB
公开号:WO2006037982A2
公开(公告)日:2006-04-13
The invention relates to substituted acids as useful pharmaceutical compounds for treating respiratory disorders as asthma, pharmaceutical compositions containing them, and processes for their preparation.